Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Breast Neoplasms × Octreotide × Clear all

Phase

Phase NA 1 Phase 4 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Weight Loss 2 Stomach Neoplasms 2 Malnutrition 2 Esophageal Neoplasms 2 Periampullary Tumors 1 Pancreatic Neuroendocrine Tumor G2 1 Pancreatic Neoplasms 1 Lymphocele 1 Endocrine System Diseases 1 Duodenal Neoplasms 1 Breast Neoplasms 1

Interventions

Exercise 92 Surveys and Questionnaires 46 Magnetic Resonance Spectroscopy 42 Acupuncture Therapy 40 Early Intervention, Educational 39 Blood Specimen Collection 37 Radiotherapy 35 Methods 35 Mammography 35 Educational Status 35 Standard of Care 34 Control Groups 30 Counseling 26 Psychiatric Rehabilitation 24 Sentinel Lymph Node Biopsy 23 Therapeutics 22 Cyclophosphamide 21 Yoga 19 Palliative Care 18 Biopsy 17 Resistance Training 16 Mastectomy, Segmental 15 Magnetic Resonance Imaging 15 High-Energy Shock Waves 15 Cognitive Behavioral Therapy 15 Interviews as Topic 13 Tamoxifen 12 Practice Guidelines as Topic 12 Paclitaxel 12 Neoadjuvant Therapy 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03791736 2022-07-28

SANDOSTATINE

Institut Cancerologie de l'Ouest

Phase NA Terminated

Breast Neoplasms, Lymphocele

Data powered by HemOnc (CC BY 4.0) Colophon ⚡